2qoe
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2qoe.jpg|left|200px]] | + | [[Image:2qoe.jpg|left|200px]] |
- | + | ||
- | '''Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor''' | + | {{Structure |
+ | |PDB= 2qoe |SIZE=350|CAPTION= <scene name='initialview01'>2qoe</scene>, resolution 2.30Å | ||
+ | |SITE= | ||
+ | |LIGAND= <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene> and <scene name='pdbligand=448:(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE'>448</scene> | ||
+ | |ACTIVITY= [http://en.wikipedia.org/wiki/Dipeptidyl-peptidase_IV Dipeptidyl-peptidase IV], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.14.5 3.4.14.5] | ||
+ | |GENE= DPP4, ADCP2, CD26 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens]) | ||
+ | }} | ||
+ | |||
+ | '''Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
- | 2QOE is a [ | + | 2QOE is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2QOE OCA]. |
==Reference== | ==Reference== | ||
- | Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors., Kowalchick JE, Leiting B, Pryor KD, Marsilio F, Wu JK, He H, Lyons KA, Eiermann GJ, Petrov A, Scapin G, Patel RA, Thornberry NA, Weber AE, Kim D, Bioorg Med Chem Lett. 2007 Nov 1;17(21):5934-9. Epub 2007 Aug 23. PMID:[http:// | + | Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors., Kowalchick JE, Leiting B, Pryor KD, Marsilio F, Wu JK, He H, Lyons KA, Eiermann GJ, Petrov A, Scapin G, Patel RA, Thornberry NA, Weber AE, Kim D, Bioorg Med Chem Lett. 2007 Nov 1;17(21):5934-9. Epub 2007 Aug 23. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/17827003 17827003] |
[[Category: Dipeptidyl-peptidase IV]] | [[Category: Dipeptidyl-peptidase IV]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Line 18: | Line 27: | ||
[[Category: NA]] | [[Category: NA]] | ||
[[Category: NAG]] | [[Category: NAG]] | ||
- | [[Category: alpha/beta | + | [[Category: alpha/beta inhibitor]] |
[[Category: aminopeptidase]] | [[Category: aminopeptidase]] | ||
[[Category: beta-propeller]] | [[Category: beta-propeller]] | ||
- | [[Category: diabetes ]] | + | [[Category: diabetes]] |
[[Category: dimer]] | [[Category: dimer]] | ||
[[Category: glycoprotein]] | [[Category: glycoprotein]] | ||
Line 32: | Line 41: | ||
[[Category: transmembrane]] | [[Category: transmembrane]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 18:27:52 2008'' |
Revision as of 16:27, 20 March 2008
| |||||||
, resolution 2.30Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , and | ||||||
Gene: | DPP4, ADCP2, CD26 (Homo sapiens) | ||||||
Activity: | Dipeptidyl-peptidase IV, with EC number 3.4.14.5 | ||||||
Coordinates: | save as pdb, mmCIF, xml |
Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor
Overview
Various beta-amino amides containing triazolopiperazine heterocycles have been prepared and evaluated as potent, selective, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. These compounds display excellent oral bioavailability and good overall pharmacokinetic profiles in preclinical species. Moreover, in vivo efficacy in an oral glucose tolerance test in lean mice is demonstrated.
About this Structure
2QOE is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors., Kowalchick JE, Leiting B, Pryor KD, Marsilio F, Wu JK, He H, Lyons KA, Eiermann GJ, Petrov A, Scapin G, Patel RA, Thornberry NA, Weber AE, Kim D, Bioorg Med Chem Lett. 2007 Nov 1;17(21):5934-9. Epub 2007 Aug 23. PMID:17827003
Page seeded by OCA on Thu Mar 20 18:27:52 2008
Categories: Dipeptidyl-peptidase IV | Homo sapiens | Single protein | Scapin, G. | 448 | NA | NAG | Alpha/beta inhibitor | Aminopeptidase | Beta-propeller | Diabetes | Dimer | Glycoprotein | Hydrolase | Membrane | Protease | Secreted | Serine protease | Signal-anchor | Transmembrane